Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Aalami Zavareh F et al. | 2021 | intact cell/cell culture | magnetic field, 50/60 Hz, low frequency | 0.2–2 mT |
Abdelhaliem EM et al. | 2022 | plant, maize (<i>Zea mais</i>) | 50/60 Hz, magnetic field | - |
Aikins AR et al. | 2017 | - | magnetic field, low frequency, 50/60 Hz | - |
Alam P et al. | 2018 | plant, <i>Artemisia annua</i> L. (seeds) | magnetic field, 50/60 Hz | - |
Amirahmadi F et al. | 2023 | intact cell/cell culture, rat bone marrow-derived stem cells | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
Amirinejad M et al. | 2024 | intact cell/cell culture, A172 and T98G (human glioblastoma cells) cell lines | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Antonini RA et al. | 2006 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | low frequency, 50/60 Hz, power transmission line, magnetic field | 1–2 mT |
Aparicio-Bautista DI et al. | 2022 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, low frequency | - |
Ardeshirylajimi A et al. | 2015 | intact cell/cell culture, human induced pluripotent stem cells | magnetic field, signals/pulses, 50/60 Hz | 1.5 mT |
Baek S et al. | 2014 | intact cell/cell culture, mouse fibroblasts, transfected with lentivirus with OKSM gene constructs from HEK293 cells | magnetic field, low frequency, 50/60 Hz, shielding/field deprivation | 1 mT |
Balcer-Kubiczek EK et al. | 1998 | DNA/RNA, intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 2 mT |
Balcer-Kubiczek EK et al. | 2000 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 2 mT |
Battini R et al. | 1991 | animal, rat/Wistar albino, whole body | magnetic field, signals/pulses, 50/60 Hz | 8 mT |
Benassi B et al. | 2019 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | 50/60 Hz, magnetic field, co-exposure | 1 mT |
Benfante R et al. | 2008 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, signals/pulses, 50/60 Hz, power transmission line | 1–2 mT |
Bernal-Mondragón C et al. | 2016 | animal, rat/Wistar, whole body | magnetic field, 50/60 Hz | 1 mT |
Binninger DM et al. | 1997 | intact cell/cell culture, <i>Saccharomyces cerevisiae</i>/D7 | magnetic field, 50/60 Hz | 20 µT |
Blank M et al. | 1994 | - | magnetic field, 50/60 Hz, co-exposure | - |
Bodega G et al. | 2005 | intact cell/cell culture, astroglial cells of P0-P1 Wistar rats | magnetic field, static magnetic field, 50/60 Hz | 1 mT |
Bouwens M et al. | 2012 | intact cell/cell culture, Detroit 562 cells (human pharyngeal cells), THP-1 cells (human monocytic leukemia cell line) and human monocytes | magnetic field, low frequency, 50/60 Hz | 5 µT |
Cadossi R | 1990 | intact cell/cell culture, human peripheral blood lymphocytes (from normal donors, donors with chronic lymphocytic leukemia, and elderly donors), animal, C3H mice, whole body | magnetic field, low frequency, signals/pulses, 50/60 Hz, co-exposure | - |
Calabro E | 2016 | intact cell/cell culture, SH-SY5Y cells (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 1 mT |
Caliogna L et al. | 2022 | intact cell/cell culture, human adipose-derived mesenchymal stem cells and primary human osteoblasts | magnetic field, signals/pulses, 50/60 Hz, therapeutic/medical device | - |
Campbell-Beachler M et al. | 1998 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz, co-exposure | 12.5–100 µT |
Chakraborty A et al. | 2022 | animal, rat/Wistar | magnetic field, 50/60 Hz | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.